Dual mobility cups in total hip arthroplasty

Table 1 Main published results of dual mobility cups in total hip arthroplasty

Ref	N. of hips	Indication	Mean FU	Implant design (cup)	Head size (mm)	Intraprostheticdislocation (%)	Dislocationrate (%)
Boyer et al[25], 2012	240	Primary THA	22 yr	Novae®1	22.2	4.1	0
Farizon et al[23], 1998	135	Primary THA	12 yr	Novae®1	22.2	2	0
Lautridou et al[24], 2008	437	Primary THA	16.5 yr	Novae-1®1	22.2	0.7	1.1
Philippot et al[47], 2006	106	Primary THA	10 yr	Novae-1®1	22.2	1.9	0
Philippot et al[12], 2009	384	Primary THA	15.3 yr	Novae-1®1	22.2	3.6	0
Philippot et al[48], 2008	438	Primary THA	17 yr	Novae-1®1	22.2	5.2	0
Guyen et al[19], 2007	167	Primary THA	3 yr	Saturne®2	n/a	0	0
Leclercq et al[20], 2008	200	Primary THA	6 yr	Evora®3	22.2 (n = 175) 26 (n = 18) 28 (n = 7)	0	0
Hamadouche et al[56], 2012	168	Primary THA	6 yr	Tregor®4	22.2	2.4	0
Vielpeau et al[21], 2011	437 (Group A) 231 (Group B)	Primary THA	16.5 yr 5.2 yr	Original Bousquet Novae-E®1	22.2	0.7 0	0 0
Bouchet et al[54], 2011	105	Primary THA	2.3 yr	Novae®1, Statfit®5, Avantage®6, Gyros®7	28	n/a	0
Bauchu et al[60], 2008	150	Primary THA	6.2 yr	Polarcup®8 3rd gen	n/a	0	0
Combes et al[22], 2013	2480	Primary THA	7 yr	Novae®1, Avantage®6, Collegia®9, EOL®10, Gyros®7, Tregor®4, Polarcup®8, Saturne®2, Evora®3	28 (n = 1484) 22 (n = 956)	0.1 0.6	0.7 0.5
Tarasevicius et al[36], 2010	42	Neck Fractures	1 yr	Avantage®6	28	n/a	0
Adam et al[35], 2012	214	Neck Fractures	3-9 mo	Saturne®2	28 (n = 182) 22.2 (n = 32)	0	1.4
Sanders et al[44], 2013	10	Spastic disorders	3.2 yr	Avantage®6	n/a	0	0
Philippeau et al[37], 2010	71	Tumor resection	3.3 yr	Avantage®6, Saturn®2, Novae®1, other	n/a	n/a	9.8
Langlais et al[17], 2008	85	Revision THA	3.2 yr	Tregor®4	22	n/a	1.1
Leiber-Wackenheim et al[14], 2011	59	Revision THA	8 yr	Novae-1®1 Novae-E®1	28	0	1.7
Hamadouche et al[31], 2010	51	Revision THA	4.3 yr	Tregor®4	22.2	2	2
Guyen et al[16], 2009	54	Revision THA	3.9 yr	Saturne®2	n/a	3.7	1.8
Hailer et al[61], 2012	228	Revision THA	2 yr	Avantage®6	n/a	n/a	2
Philippot et al[30], 2009	163	Revision THA	5 yr	Novae®1	22.2	0	3.7

¹Serf, Décines, France; ²Amplitude, Valence, France; ³Science et Médecine, Créteil, France; ⁴Aston, St Etienne, France; ⁵Zimmer, Etupes, France; ⁶Biomet, Valence, France; ⁷DePuy, St Priest, France; ⁸Smith and Nephew Orthopaedics AG, Rotkreuz, Switzerland; ⁹Cremascoli-Wright, Paris, France; ¹⁰Norton-Ceramconcept, Paris, France. n/a: Not available.